Timothy Flanigan Ph.D.

Research Psychologist — Division of Neurotoxicology

Timothy Flanigan, Ph.D.
(870) 543-7391
NCTRResearch@fda.hhs.gov

Back to NCTR Principal Investigators page

Background

Dr. Timothy Flanigan received his Ph.D. in experimental psychology with a concentration in behavioral neuroscience in 2011. There he studied the role of genetics in anxiety- and depression-like behavior using mouse models. He went on to complete a postdoctoral fellowship in the Department of Neurology at the University of Tennessee Health Science Center. During that time, he conducted research using the 5xFAD mouse model of Alzheimer’s Disease and investigated the potential of manipulating brain gangliosides as a treatment. In 2015, Dr. Flanigan was recruited to NCTR as an ORISE postdoctoral fellow. He served on NCTR’s monograph team for nearly three years helping to create comprehensive reviews on over 50 compounds. He also conducted research examining the cognitive effects of chemotherapeutic agents, anesthesia, and developmental exposure to arsenic. In 2018, Dr. Flanigan became a staff fellow in the Division of Neurotoxicology.

Research Interests

Dr. Flanigan has a broad interest in behavioral neuroscience and neurotoxicology. He is particularly interested in cognitive and affective behaviors and modeling them in rodents. He is also interested in how genetics, development, and aging interact with drugs and toxicants to affect these behaviors.